This introduction challenges the traditional assumption that cancer-associated fibroblasts (CAFs) function as a single, uniform population in pancreatic cancer. Instead, the authors highlight a key gap in the field: while CAFs are known to contribute to tumor progression, extracellular matrix (ECM) deposition, and therapy resistance, it remains unclear whether all CAFs perform the same functions or whether distinct subpopulations exist. They emphasize that pancreatic ductal adenocarcinoma (PDAC) is characterized by extensive desmoplasia, where fibroblasts make up a large portion of the tumor mass and actively influence tumor behavior. Importantly, CAFs are not just structural components but secrete signaling molecules that regulate cancer progression and treatment response. This sets up the central question of the study: whether CAF heterogeneity exists, and if so, how different fibroblast subtypes contribute uniquely to the tumor microenvironment. The introduction therefore reframes fibroblasts as dynamic and functionally specialized players within the TME, rather than passive supporters of tumor growth. This introduction aligns with a broader shift in cancer biology toward understanding the tumor microenvironment as a heterogeneous and interactive system, where non-cancer cells play active and possibly opposing roles in disease progression.